[Golden Evening Report | Key Developments from 12:00 to 21:00 on October 31] Keywords: Baseten, Vitalik, NYSE
1. Today marks the 18th anniversary of the Bitcoin whitepaper's release.
2. NVIDIA invests in AI inference startup Baseten, which plans to raise $2 billion
3. Vitalik posts advocating "digital minimalism," sharing experiments with social media, phone, and web usage.
4. ICE reissues the trade.xyz partnership announcement, including "planned introduction" and "subject to regulatory approval"
5. CZ clarifies that he did not threaten Musk with money, emphasizing that his ownership of SPCX shares was solely to demonstrate financial capability.
6. ICE, the parent company of the New York Stock Exchange, deleted its tweet regarding the partnership with trade.xyz, but the official website still retains the partnership announcement.
Bitcoin Whitepaper Turns 18, NVIDIA Invests in Baseten, Vitalik Advocates Digital Minimalism
JinseShare
Digital Asset News Highlights, October 31: The Bitcoin whitepaper turns 18, marking a milestone in crypto history. NVIDIA invests in AI firm Baseten, which is seeking $2 billion in funding. Vitalik Buterin promotes digital minimalism, sharing personal experiments with technology use. ICE reissues its collaboration with trade.xyz, noting regulatory review. CZ denies pressuring Musk, stating that SPCX holdings demonstrated financial strength. ICE removes a tweet but retains the partnership statement online. Digital collectibles news remains quiet amid broader market updates.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.

